Michael Boyne

Company: COUR Pharmaceuticals
Job title: Vice President of Product Development & Analytics
Seminars:
Exploring T Cells: Treg Cell interaction & their Implications in Aiding Therapeutic Strategies 10:30 am
Unravelling the Diversity of B&T Cell Directed Drug Modalities Peripheral tolerance, preventing autoimmune diseases and limiting chronic inflammatory diseases Treg instability, plasticity and tissue-specific Treg cellsRead more
day: Day Two